Moderna to begin clinical trials of Covid booster shots for variant from South Africa, sends to NIH for study

Moderna said it has shipped to the NIH doses of a new Covid-19 vaccine designed to provide better protection against the South Africa variant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.